Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

Study shows ctDNA positivity is the most prognostic factor, demonstrating the potential for Signatera to redefine adjuvant treatment pathways in endometrial cancer This real-world study analyzed 267 ...

Dr Robert DeBernardo explains how new immunotherapies are reshaping care and how their earlier availability might have ...

Acrivon Therapeutics is developing a targeted oncology therapy with a companion proteomics-based signature, showing promising activity in their lead compound for certain patients with gynecologic ...

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

Preterm delivery skyrocketed in PE pregnancies: Over 22% of Swedish and 24% of Finnish women with preeclampsia delivered before 37 weeks, far exceeding the 5-6% rate in unaffected pregnancies. In a ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

Surviving cancer isn’t just about beating a disease. It’s about showing up every single day when your body and mind are ...